View Author
cancer breast bcar 4 resistance expression breast cancer tamoxifen receptor protein erbb 2 tamoxifen resistance estrogen breast cancer cells zr /bcar cells level cell lines patient pathway bcar 4 expression therapy tumor growth proliferation lapatinib antiestrogen factor zr -75-1 cells treatment chapter mechanism /bcar presence breast cancer res -75-1 study agthoven analysis estrogen receptor kinase survival j clin oncol antiestrogen resistance effect bcar 4-expressing cells cancer res inhibitor 4- oht medium zr /egfr cells phosphorylation activation esr 1 homologue culture control function erbb 3 erbb receptors development result clin cancer res breast cancer patients disease tissue breast cancers 2007. netherland gene expression model addition bcar 4 mrna inhibition estradiol tamoxifen treatment response 4- hydroxytamoxifen br j cancer nat rev cancer anti-estrogen progression
3 Most Recent Publications
|
The role of BCAR4 in tamoxifen resistant breast cancer
(Doctoral Thesis)
Ernesto Godinho, M.F. |
2012-06-27
|
|
Characterization of BCAR4, a novel oncogene causing endocrine resistance in human breast cancer cells
(Article)
Ernesto Godinho, M.F. Meijer, D. Setyono-Han, B. Dorssers, L.C.J. Agthoven, T.L.A. van |
2011-07-01
|
|
Endothelial nitric oxide synthase overexpression restores the efficiency of bone marrow mononuclear cell-based therapy
(Article)
Mees, B.M.E Récalde, A. Loinard, C. Tempel, D. Ernesto Godinho, M.F. Vilar, J. Haperen, R. van Lévy, B. Silvestre, J.S. Crom, M.P.G. de |
2011-01-01
|